Portage Biotech logo

Portage Biotech Share Price (NASDAQ: PRTG)

$7.2

-0.07

(-0.96%)

Last updated on

Check the interactive Portage Biotech Stock chart to analyse performance

Portage Biotech stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$7.20
    Today's High:$7.47

    Day's Volatility :3.61%

  • 52 Weeks Low:$2.81
    52 Weeks High:$23.01

    52 Weeks Volatility :87.79%

Portage Biotech Stock Returns

PeriodPortage Biotech IncSector (Health Care)Index (Russel 2000)
3 Months
-5.89%
3.6%
0.0%
6 Months
75.6%
-7.7%
0.0%
1 Year
96.49%
-12.6%
0.0%
3 Years
-95.33%
9.5%
-4.7%

Portage Biotech Inc Key Stats

Check Portage Biotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.27
Open
$7.46
Today's High
$7.47
Today's Low
$7.2
Market Capitalization
$16.8M
Today's Volume
$42.1K
52 Week High
$23.01
52 Week Low
$2.81
Revenue TTM
$0.0
EBITDA
$-7.4M
Earnings Per Share (EPS)
$-5.72
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-541.81%

Stock Returns calculator for Portage Biotech Stock including INR - Dollar returns

The Portage Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Portage Biotech investment value today

Current value as on today

₹1,99,879

Returns

₹99,879

(+99.88%)

Returns from Portage Biotech Stock

₹94,595 (+94.59%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Portage Biotech Stock

17%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Portage Biotech Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Portage Biotech Inc

  • Name

    Holdings %

  • QTR Family Wealth, LLC

    0.85%

  • UBS Group AG

    0.45%

  • BlackRock Inc

    0.02%

  • Morgan Stanley - Brokerage Accounts

    0.01%

Analyst Recommendation on Portage Biotech Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Portage Biotech(by analysts ranked 0 to 5 stars)

Portage Biotech Share Price Target

What analysts predicted

Upside of 1844.44%

Target:

$140.00

Current:

$7.20

Portage Biotech share price target is $140.00, a slight Upside of 1844.44% compared to current price of $7.20 as per analysts' prediction.

Portage Biotech Stock Insights

  • Price Movement

    In the last 7 days, PRTG stock has moved down by -20.2%
  • PRTG vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 207.8%

Portage Biotech Technicals Summary

Sell

Neutral

Buy

Portage Biotech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Portage Biotech Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Portage Biotech Inc logo
21.98%
75.6%
96.49%
-95.33%
-99.01%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Portage Biotech Inc

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors; PORT-6, a highly selective A2A receptor antagonist, which is in phase 1a for the treatment of solid tumors; PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials; and PORT-7, a potent and selective antagonist of the adenosine A2B receptor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Organization
Portage Biotech
Employees
3
CEO
Mr. Peter Molloy
Industry
Healthcare

Key Management of Portage Biotech Inc

NameTitle
Mr. Alexander Pickett
CEO & Director
Ms. Eun-Jae Park CPA
Chief Financial Officer
Dr. Robert A. Kramer Ph.D.
Chief Scientific Officer
Adam Melero
Controller
Mr. Peter Molloy
Chief Executive Officer of Cyncado Therapeutics Inc.

Important FAQs about investing in PRTG Stock from India :

What is Portage Biotech share price today?

Portage Biotech share price today is $7.20 as on at the close of the market. Portage Biotech share today touched a day high of $7.47 and a low of $7.20.

What is the 52 week high and 52 week low for Portage Biotech share?

Portage Biotech share touched a 52 week high of $23.01 and a 52 week low of $2.81. Portage Biotech stock price today i.e. is closed at $7.20, lower by 68.71% versus the 52 week high.

How to invest in Portage Biotech Stock (PRTG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Portage Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Portage Biotech Shares that will get you 0.2083 shares as per Portage Biotech share price of $7.20 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Portage Biotech Stock (PRTG) from India?

Indian investors can start investing in Portage Biotech (PRTG) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Portage Biotech stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Portage Biotech share’s latest price of $7.20 as on August 30, 2025 at 1:29 am IST, you will get 1.3889 shares of Portage Biotech. Learn more about fractional shares .

What are the returns that Portage Biotech has given to Indian investors in the last 5 years?

Portage Biotech stock has given -99.01% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?